TARGEDYS
TargEDys develops mechanisms involving hormone mimetic proteins linked to microbiota for the treatment of eating disorders such as hyperphagia or anorexia. The company was incorporated in 2011 and is based in Rouen, Fran
TARGEDYS
Industry:
Biotechnology Health Care Medical Device
Founded:
2015-01-01
Address:
Saulx-les-chartreux, Ile-de-France, France
Country:
France
Website Url:
http://www.targedys.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 72 48 84 57
Email Addresses:
[email protected]
Total Funding:
10.26 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network SSL By Default JsDelivr
Similar Organizations
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Investors List
Zaluvida Ventures
Zaluvida Ventures investment in Series A - TargEDys
NCI Gestion
NCI Gestion investment in Series A - TargEDys
Seventure Partners
Seventure Partners investment in Series A - TargEDys
Pontifax
Pontifax investment in Series A - TargEDys
Pontifax
Pontifax investment in Series A - TargEDys
Seventure Partners
Seventure Partners investment in Series A - TargEDys
NCI Gestion
NCI Gestion investment in Series A - TargEDys
Normandie Incubation
Normandie Incubation investment in Non Equity Assistance - TargEDys
Official Site Inspections
http://www.targedys.com
- Host name: cdn.perf1.com
- IP address: 152.89.172.56
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "TargEDys"
Targedys
We are pleased to announce that the journey of TargEDys continues alongside Biocodex! As we embark on this new chapter together, we invite you to visit www.biocodex.com for more …See details»
TargEDys - Crunchbase Company Profile & Funding
Organization. TargEDys . Connect to CRM . Save . Summary. Financials. …See details»
Biocodex fully acquires TargEDys - Microbiome Times Magazine
Jun 6, 2023 TargEDys and Biocodex have been partners since 2019, when Biocodex became a shareholder and board member of TargEDys. Soon after, Biocodex became the distributor of …See details»
TargEDys acquired by pharma partner Biocodex - NutraIngredients
Jun 7, 2023 TargEDys is a commercial-stage French biotech company specialising in the development of nutraceutical solutions for the control of appetite through microbiome …See details»
TargEDys - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 TargEDys is an acquired company based in Rouen (France), founded in 2015. It operates as a Provider of microbiome-based solutions for appetite regulation. TargEDys has …See details»
TargEDys - MicrobiomePost
Targedys is a commercial stage french biotech specialized in precision probiotics, or precibiomic strains, with their mechanism of action identified and characterized in scientific publications. …See details»
Seventure and minority shareholders have sold TargEDys to …
TargEDys is an innovative French biotechnology that is pioneering disruptive microbiome-based solutions, mainly addressing weight management, growth and anxiety health challenges. The …See details»
TargEDys Company Profile - Office Locations, Competitors ... - Craft
TargEDys has 5 employees across 2 locations and $10.24 m in total funding,. See insights on TargEDys including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
TargEDys - VentureRadar
TargEDys is an innovative start-up whose activity is based on world-leading research from company founders Serguei Fetissov and Pierre Déchelotte, who have identified and described …See details»
TargEdys - Golden
Organization. Company. Company attributes. Industry. ... TargEDys focuses on the modulation of appetite and develops functional food, medical food, and pharmaceutical products to harness …See details»
TargEDys - Company info. interviews, news
Mar 18, 2020 TargEDys is a clinical stage biotech company based in France with offices in Rouen and Longjumeau, Paris. TargEDys has raised over €10M in Series A funding to …See details»
TargEDys - Updates, News, Events, Signals & Triggers - Crunchbase
Feb 22, 2022 TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.See details»
Biocodex becomes the sole shareholder of TargEDys
Jun 6, 2023 Soon after, Biocodex became the distributor of TargEDys’ leading PreciBiomic, Symbiosys Satylia®, in France, then in Portugal and Poland. Now, the French family company …See details»
Targedys - Facebook
Targedys. 293 likes. Our Mission --- develop functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.See details»
TargEDys - Biotech Careers
TargEDys® translates its unique understanding of the gut-brain axis to develop and manufacture nutritional and therapeutic solutions to control metabolic diseases. Business Areas: …See details»
TargEDys - Contacts, Employees, Board Members, Advisors & Alumni
TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.See details»
TargEDys - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... Apr 14, 2016: Series A - TargEDys . 3: …See details»
TargEDys, a French microbiome start-up, collects the award for …
Nov 25, 2019 EnteroSatys® is a dietary supplement which was developed by TargEDys as a result of more than 15 years of research on microbiome and the gut-brain axis, in cooperation …See details»
TargEDys - Tech Stack, Apps, Patents & Trademarks - Crunchbase
TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite. New. Resources. Advanced Search. Start Free Trial . …See details»